NatWest Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,525
| Closed | -$326K | – | 54 |
|
|
2023
Q1 | $326K | Hold |
2,525
| – | – | 0.18% | 41 |
|
|
2022
Q4 | $322K | Hold |
2,525
| – | – | 0.18% | 45 |
|
|
2022
Q3 | $264K | Hold |
2,525
| – | – | 0.15% | 45 |
|
|
2022
Q2 | $265K | Hold |
2,525
| – | – | 0.15% | 46 |
|
|
2022
Q1 | $323K | Sell |
2,525
-76
| -3% | -$9.16K | 0.16% | 47 |
|
|
2021
Q4 | $321K | Hold |
2,601
| – | – | 0.17% | 41 |
|
|
2021
Q3 | $370K | Hold |
2,601
| – | – | 0.2% | 50 |
|
|
2021
Q2 | $406K | Sell |
2,601
-515
| -17% | -$83.4K | 0.21% | 48 |
|
|
2021
Q1 | $484K | Sell |
3,116
-4,200
| -57% | -$651K | 0.23% | 49 |
|
|
2020
Q4 | $1.09M | Sell |
7,316
-1,494
| -17% | -$211K | 0.4% | 50 |
|
|
2020
Q3 | $1.16M | Hold |
8,810
| – | – | 0.25% | 53 |
|
|
2020
Q2 | $1.02M | Sell |
8,810
-696
| -7% | -$80.2K | 0.28% | 40 |
|
|
2020
Q1 | $933K | Buy |
9,506
+1,679
| +21% | +$220K | 0.26% | 49 |
|
|
2019
Q4 | $1.14M | Sell |
7,827
-1,734
| -18% | -$239K | 0.24% | 53 |
|
|
2019
Q3 | $1.27M | Sell |
9,561
-1,453
| -13% | -$188K | 0.31% | 45 |
|
|
2019
Q2 | $1.26M | Sell |
11,014
-210
| -2% | -$24.6K | 0.23% | 48 |
|
|
2019
Q1 | $1.39M | Sell |
11,224
-2,060
| -16% | -$234K | 0.28% | 41 |
|
|
2018
Q4 | $1.34M | Sell |
13,284
-58
| -0.4% | -$6.52K | 0.29% | 42 |
|
|
2018
Q3 | $1.7M | Sell |
13,342
-247
| -2% | -$29.4K | 0.31% | 39 |
|
|
2018
Q2 | $1.47M | Sell |
13,589
-638
| -4% | -$69.4K | 0.3% | 41 |
|
|
2018
Q1 | $1.51M | Sell |
14,227
-26
| -0.2% | -$3.02K | 0.32% | 40 |
|
|
2017
Q4 | $1.67M | Sell |
14,253
-1,078
| -7% | -$122K | 0.38% | 38 |
|
|
2017
Q3 | $1.74M | Sell |
15,331
-34,420
| -69% | -$3.97M | 0.43% | 38 |
|
|
2017
Q2 | $6.2M | Sell |
49,751
-7,600
| -13% | -$901K | 1.44% | 16 |
|
|
2017
Q1 | $6.8M | Sell |
57,351
-1,432
| -2% | -$162K | 1.45% | 20 |
|
|
2016
Q4 | $5.89M | Buy |
58,783
+1,734
| +3% | +$186K | 1.55% | 19 |
|
|
2016
Q3 | $7.2M | Sell |
57,049
-22,947
| -29% | -$2.84M | 1.7% | 23 |
|
|
2016
Q2 | $9.35M | Sell |
79,996
-41,359
| -34% | -$4.68M | 2.36% | 12 |
|
|
2016
Q1 | $12.6M | Sell |
121,355
-11,699
| -9% | -$1.13M | 2.81% | 10 |
|
|
2015
Q4 | $13.3M | Sell |
133,054
-15,735
| -11% | -$1.54M | 2.66% | 12 |
|
|
2015
Q3 | $13.6M | Sell |
148,789
-1,349
| -0.9% | -$135K | 0.3% | 33 |
|
|
2015
Q2 | $15.9M | Sell |
150,138
-5,872
| -4% | -$650K | 0.2% | 29 |
|
|
2015
Q1 | $17.8M | Sell |
156,010
-1,908
| -1% | -$218K | 0.23% | 22 |
|
|
2014
Q4 | $17.4K | Sell |
157,918
-68,551
| -30% | -$7.23M | 0.15% | 24 |
|
|
2014
Q3 | $22.1K | Buy |
226,469
+19,825
| +10% | +$1.95M | 0.19% | 22 |
|
|
2014
Q2 | $20.8M | Sell |
206,644
-19,892
| -9% | -$1.94M | 0.88% | 23 |
|
|
2014
Q1 | $20.8M | Buy |
226,536
+35,013
| +18% | +$3.23M | 0.92% | 22 |
|
|
2013
Q4 | $17.3M | Sell |
191,523
-15,583
| -8% | -$1.35M | 0.44% | 53 |
|
|
2013
Q3 | $16.5M | Buy |
207,106
+20,941
| +11% | +$1.65M | 0.48% | 49 |
|
|
2013
Q2 | $13.5M | Buy |
+186,165
| New | +$13.9M | 0.19% | 94 |
|
Other funds holding ZBH
NatWest Group's ZBH Position: Q2 2023 in Review
NatWest Group sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 2,525 shares — an estimated $326K sold.
NatWest Group first reported a position in ZBH in Q2 2013 and held it in 40 quarters. The position peaked at $20.8M in Q2 2014. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.
- NatWest Group reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
- NatWest Group sold 2,525 Zimmer Biomet shares in Q2 2023, an estimated $326K.
- NatWest Group first reported a position in Zimmer Biomet in Q2 2013 and held it in 40 quarters.
- NatWest Group's Zimmer Biomet position peaked at $20.8M in Q2 2014.
- 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.
Based on NatWest Group's 13F filing for Q2 2023, filed 25 Jul 2023.